14.3 Aftercare and Adverse Reactions
Key Takeaways
- Expected post-exfoliation signs include mild erythema, tightness, and light flaking; adverse signs include blistering or weeping burns, frosting beyond the intended level, frostbite-style white waxy injury, delayed PIH, and infection.
- Stop a peel when the client reports sharp burning, or when frosting exceeds what the labeled superficial protocol intends; tingling and even pink are not automatic permission to add more acid.
- Immediate response is remove or neutralize only as the manufacturer requires, apply a cool compress, and do not apply more acid; then document product, time, response, and actions.
- Refer to a physician for burns, suspected infection, or tissue-injury patterns you cannot manage as cosmetics; do not diagnose the disease you are referring.
- 68 Ill. Adm. Code 1175.120 treats departure from standards of practice as unprofessional conduct even when actual injury is not established, and using a chemical contrary to manufacturer indication is its own 1175.120 count.
14.3 Aftercare and Adverse Reactions
Quick Answer: Expected after a superficial peel or mechanical pass: mild erythema, tightness, light flaking. Adverse: blistering or weeping burn, frosting beyond what the labeled protocol intends, frostbite-style white waxy injury, delayed PIH, infection. If the client reports sharp burning or you see frosting you did not mean to create, stop, remove or neutralize as labeled, cool, and do not apply more acid. Document. Refer burns and infection. 1175.120 can treat a departure from standards of practice as unprofessional conduct even without actual injury. Follow the manufacturer indication.
NIC II.I.3 after care is not only a product list. It is the skill of telling normal recovery from harm, acting in the first minute of harm, and writing it down. Illinois then adds professional-conduct law. 68 Ill. Adm. Code 1175.120 interprets dishonorable, unethical, or unprofessional conduct under Section 4-7 of the Act. Actual injury to a client need not be established for several of those counts, including departing from standards of practice and using a chemical contrary to the manufacturer’s indication. A peel that “mostly went fine” is still a conduct problem if you ignored the label, stacked wax then acid, or kept going after frosting you were not supposed to create.
Expected versus adverse
Teach the client — and yourself — the difference before the timer starts. After care that only says “you will peel, don’t worry” hides burns inside normal language.
Expected (still watch it):
- Mild erythema (pink from capillary dilation), like a light flush, that eases with cool air and a soothing finish
- Tightness or slight sting that settles when the product is removed or neutralized as labeled
- Light flaking or roughness over the next several days as corneocytes shed
- Temporary sensitivity to cleanser, fragrance, and sun
Adverse (stop, manage, document, refer when indicated):
- Burn: intense pain, blistering, weeping, crusting, gray-white persistent pallor, or edema that is not a mild flush. Erythema that deepens into a second-degree pattern is not “a strong facial.”
- Frosting beyond intended: a white, frost-like protein coagulation on the surface. In medical medium and deep peels, clinicians grade frost on purpose. In Illinois esthetics, a labeled superficial enzyme, AHA, or BHA is not a frosting contest. A faint, quickly fading haze that the manufacturer describes is not the same as a thick, spreading white sheet. If frosting is more than the protocol intended, treat it as an endpoint you have passed, not as proof the peel “is working.”
- Frostbite-style injury: tissue that looks white, waxy, numb, or hard, as if frozen or chemically cooked, not a transient frost. This is injury, not a successful coagulation. Do not keep applying product to “even the frost.” Cool, stop all acid, and refer.
- Delayed PIH: dark patches that appear days later, especially on Fitzpatrick IV–VI, after inflammation plus sun. Prevention is conservative depth plus SPF (Section 14.2). Once it appears, you do not peel harder to “lift the pigment,” and you do not diagnose the patch as a disease you will treat.
- Infection: increasing pain, spreading redness, pus, feverish feeling, honey-colored crust beyond ordinary flaking. Superficial exfoliation is not sterile surgery, but a broken barrier plus dirty hands, double-dipped product (1175.115), or picking can infect. You do not prescribe antibiotics. You refer.
| Sign | Teaching meaning | First action |
|---|---|---|
| Mild pink, eases after rinse | Expected erythema | Finish, SPF, written after care |
| Sharp burning the client cannot tolerate | Adverse — you have gone too far or the skin was not a candidate | Stop the peel |
| Transient faint haze the label describes | Possible intended endpoint for that product | Follow the labeled next step; do not add acid |
| Thick spreading white frost you did not intend | Adverse frosting | Remove/neutralize as labeled; cool; no more acid |
| White, waxy, numb, hard tissue | Frostbite-style chemical injury | Stop; cool; physician referral |
| Blisters, weep, crust | Burn | Stop; cool; refer; do not pick or peel blisters |
| Dark patches days later | Delayed PIH | Sun protection; do not stack more acid; refer if unsure |
| Spreading redness, pus, feverish | Suspected infection | Do not treat as a facial; refer |
When to stop a peel
Two verbal and visual triggers are high-yield:
- The client reports sharp burning — not “tingly,” not “warm,” sharp. Superficial acids can tingle. Sharp, escalating pain means the product is injuring more than dead cells, the skin was contraindicated, or the time/dose is already too much.
- You see frosting beyond intended — a white sheet that is spreading, thickening, or appearing on a product that was never supposed to frost.
Other immediate stops: product in the eye, pooling in the nasolabial folds that the client feels as fire, hives, wheezing, or a vasovagal faint. 1175.115 already forbade starting on inflamed or erupting skin; if vesicles appear under the acid, you are now on infected skin — stop.
Cool, neutralize if required, do not apply more acid
The first-aid order is the opposite of a hero pass.
- Stop applying. Put the brush down. Do not “blend the edge” with a second layer.
- Remove or neutralize only as the manufacturer requires. Some AHAs use a labeled buffer. Many BHA and enzyme protocols are water-rinsed, not kitchen-neutralized. Inventing a baking-soda paste because a classmate did it is both a burn risk and 1175.120 off-label use.
- Cool compress (clean, not a multi-use spa stone from the warmer). Cool reduces inflammation. Ice held hard enough to freeze tissue is how you add a frostbite-style injury to a chemical one — do not do that.
- Do not apply more acid, more crystals, a “calming peel,” or a home AHA sample “to even the frost.” The injury is already the extra dose.
- Finish only if the skin has clearly returned to an expected mild pink: bland hydrator, no fragrance blast, and SPF if they can tolerate it. If they cannot, send them with written sun-avoidance and a follow-up check.
- Document while it is fresh: product name and that it was indicated as superficial, exact time on skin, where it was applied, what the client said (sharp burning), what you saw (frosting, blister), what you did (rinsed, labeled neutralizer, cool compress), what you did not do (no second layer), after-care instructions, and any referral. Observational language. You are not writing a medical diagnosis of “second-degree chemical burn, start steroids.”
Refer to a physician for burns, suspected infection, eye exposure that does not clear, frostbite-style injury, or any pattern you cannot honestly call expected flaking. Give the client the product name and SDS-relevant first-aid facts you used. Do not tell them “it is definitely cellulitis” or “you do not need a doctor if you buy this cream.” 3A-1 still forbids medical-treatment advice.
1175.120 and the manufacturer indication
1175.120 is the professional-conduct overlay on every peel, brush pass, and after-care speech.
- Departure from standards of practice — including sanitation, on-label chemical procedure, and staying in scope — can be unprofessional conduct. Actual injury need not be established. Leaving acid on past the labeled window “because nothing bad happened last time” is still a standard-of-practice problem. So is skipping intake, stacking wax then peel, and advertising a medium TCA as an esthetician facial.
- Using a product contrary to the manufacturer’s indication is its own count (the rule’s famous example is scalp dye on eyebrows). A peel left on twice as long as labeled, mixed with a second acid the manufacturer never combined, or used on broken skin the box forbids is that count — whether or not a blister forms.
- Practice beyond legal scope is a separate count: living-layer peels, microneedling billed as exfoliation, and holding delegated medicine out as esthetics.
Follow the SDS for splash and first aid (Chapter 5) and the label for time, neutralization, and contraindications. The SDS does not enlarge scope. The manufacturer indication is the standard 1175.120 tells you not to depart from. If the box says rinse at three minutes, you rinse at three minutes. If it says not for use on inflamed skin, you never started. If it says superficial / cosmetic, you do not chase frosting as if you were in a medical residency.
Aftercare that will survive an exam stem and a board complaint looks like this: expected pink versus burn taught in advance; stop on sharp burning or unintended frosting; cool; neutralize only if required; no more acid; chart; SPF and written home care for expected recovery; physician for burns and infection. Illinois does not require a client to be injured before the conduct can be unprofessional. Stay on the label, stay on the corneum, and treat frosting as a warning, not a trophy.
Which pair correctly distinguishes expected erythema after a superficial peel from an adverse burn?
During a labeled superficial AHA, the client says the face is burning sharply and you see a thick spreading white frost the protocol did not describe. What do you do?
A licensee leaves a superficial peel on twice as long as the label allows. The client happens not to blister. Which 1175.120 statement is accurate?
After an adverse peel response, which immediate sequence matches manufacturer-driven first aid and Illinois documentation?